You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / FDC

FDC
Intrinsic Value | Fundamental Analysis

Returns | 1W : -0.1% , 1M : -1.5%,1Y : 45.5%
BOM : 531599     NSE : FDC    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Jun 22,2021
Price(EOD): Rs. 359.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 6,061.61 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
FDC -0.1% -1.5% 45.5%
SUN PHARMACEUTICAL INDUSTRIES -0.4% -3.5% 37.6%
DR REDDYS LABORATORIES -1.8% 0.7% 31.9%
DIVIS LABORATORIES -0.3% 4.7% 83.8%
CIPLA -0.1% 2.7% 50.7%
BIOCON -0.5% 4.7% 6.3%
AUROBINDO PHARMA -3.6% -6.1% 21.9%
LUPIN -1.4% -3.1% 26.6%
TORRENT PHARMACEUTICALS 1.3% 7.7% 14.8%


FUNDAMENTAL ANALYSIS OF FDC

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than FDC Premium


VALUATION OF FDC

 
Valuation Score
Ratio Standalone
P/E
P/B
P/S
24.89
P/E Calculated based on EPS of 14.43
[ Mar2020 - Standalone Results ]

3.98
P/B Calculated based on Book Value of 90.18
[ Mar2020 - Standalone Results ]

4.66
P/S Calculated based on Revenues of 1300.22 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than FDC Premium


FAIR VALUE OF FDC

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
127%
72%
73%

SHARE PRICE MOMENTUM OF FDC

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0
0
0
-
0
0
0
-
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Mar2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-6.23%
-45.82%
-48.09%
-40.71%
-5.89%
39.06%
-17.11%
-28.26%
QtrlyTrend
-6
Latest Qtr: Mar2021

FDC related INDICES

BSE Indices1W1M1Y
S&P BSE 250 SMALLCAP 0.4% 6.6% 103.3%
S&P BSE SMALL CAP 0.2% 7.6% 102.4%
S&P BSE ALLCAP -0.1% 4.3% 62.2%
S&P BSE 500 -0.1% 4.1% 60.8%
S&P BSE MIDSMALLCAP -0.3% 5.8% 89.2%
S&P BSE 400 MIDSMALLCAP -0.7% 5.4% 88%
S&P BSE HEALTHCARE -0.8% 1.4% 53.6%
NSE Indices1W1M1Y
NIFTY SMALLCAP250 0.3% 6.1% 106.3%
NIFTY 500 -0.1% 4.1% 60.1%
NIFTY FREE SMALL 100 -0.2% 5.5% 110.5%
NIFTY MID SMALL400 -0.7% 5.2% 88.5%
NIFTY500 MULTICAP 50:25:25 -1.3% 4.8% NA

FAQ [Frequently Asked Questions]


Is FDC good for long term investment?

As on 22-Jun-2021, the Fundamentals of FDC are Strong and hence it's good for long term investment! See Financial Performance of FDC . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is FDC UnderValued or OverValued?

As on 22-Jun-2021, FDC is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of FDC ?

As on 22-Jun-2021, the Intrinsic Value of FDC is Rs. 207.97 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 158.49
Fair Value [Median EV / Sales Model] : Rs. 209.28
Fair Value [Median Price / Sales Model] : Rs. 207.97
Median Fair Value of FDC : Rs. 207.97

Is FDC trading at a Premium or Discount?

As on 22-Jun-2021, FDC is trading at a Premium of 73% based on the Median Intrinsic Value!

Is it right time to buy FDC shares?

As on 22-Jun-2021, FDC is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of FDC?

Check out Annual Financials of Industry Peers
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of BIOCON LTD
Quarterly Results of AUROBINDO PHARMA LTD
Quarterly Results of LUPIN LTD
Quarterly Results of TORRENT PHARMACEUTICALS LTD
Quarterly Results of CADILA HEALTHCARE LTD
Quarterly Results of ABBOTT INDIA LTD

What are the Frequent Comparisons with FDC?

Compare Analytics
FDC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
FDC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
FDC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
FDC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
FDC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
FDC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
FDC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
FDC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
FDC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of BIOCON LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of LUPIN LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z